Saturday 13th January 2024 • Promotional Content


Health, Fitness & Wellbeing New Year, Fresh Start 11


Unlocking your DNA with Medicover Genetics A


s we step into 2024, Medicover Genetics invites you


embark on a journey of health


and wellbeing through the lens of genetic medicine. With over 25 years of expertise in genetic diagnostics, it stands as a leading healthcare company, committed to placing genetics at the core of medical decisions.


If you are pregnant or interested in conceiving Medicover Genetics supports you with personalised insights for better family planning. • Adventia® carrier screening can provide meaningful results to mini- mise the risk of transmitting a genetic disorder to your children. • Infertility can be caused by genetic changes — the Rodinia® infertility test can identify the cause and help establish the optimal treatment. • Amfira® can be used during in vitro fertilisation cycles to test embryos for higher chances in resulting pregnancy. • During pregnancy, foetal DNA travels from the placenta to the mother’s bloodstream and circulates along with her own DNA. Medicover


Genetics' to proprietary non-inva-


sive prenatal tests, VERACITY® and VERAgene®, can detect poten- tial changes in the genome of foetal DNA, including trisomies and microdeletions.


If you have a strong family history of cancer or are diagnosed with cancer Te risk of cancer development can be estimated with hereditary cancer panels, for conditions such as breast or colon cancer, prompting proac- tive health measures such as routine monitoring. For patients dealing with cancer,


the somatic tumour tests Detect&Act and ForeSentia® — in addition to NeoTetis® liquid biopsy — can guide choices towards targeted therapies and precision medicine.


If you are a parent of a child with symptoms of unknown origin With Pediatric Global Delay Define&Decide, parents can receive a clear diagnosis for a child with global developmental delay or intellectual disability, empowering them to make informed decisions on the manage- ment plan or treatment options.


If you are a physician With a broad genetic testing port- folio, you can identify the right test for your patient and receive compre- hensive reports and dedicated clin- ical support from the team of medical geneticists.


Whole exome and whole genome sequencing Next generation sequencing (NGS) allows multiple small sequences of DNA to be analysed in parallel. Whole exome sequencing uses NGS for the simultaneous analysis of the exons (protein-coding sections) of around 20,000 genes, while whole genome sequencing includes all exons and non-coding sections of genes. Both methods are used to increase the likelihood of identifying the


genetic cause of disorders charac- terised by complex and non-typical symptoms. Results can help decide on management and treatment plans, offering valuable insights for future pregnancies, and may prompt other family members to get tested.


Curious about genetics generally? Discover a wealth of knowledge in the blog articles posted weekly on Medicover Genetics' website (medicover-genetics.com). Delve into insights on diverse subjects such as the correlation between genetics, feeling cold and its effects on other conditions;


the ‘high pitch’ gene;


the link between genetics and sleep apnoea; and the intricate relation- ship between travel, gut health and antibiotic resistance.


E: info.genetics@medicover.com Visit: medicover-genetics.com


Genetic testing is a powerful


tool for understanding your health. Make informed decisions with Medicover Genetics.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40